788826: Bard InLay Optima Ureteral Stent 26cm x 8F

Sign in to add this product to your favorites!
| Price: | $79.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 4 box of 1 |
| Expiration: | 11-2026 |
| Express: | Need it tomorrow? Order in next 11 hours 50 minutes and choose overnight shipping at checkout. |
Additional Details
BD Bard INLAY OPTIMA® URETERAL STENT
The INLAY OPTIMA® stent continues the legacy of the BARD® INLAY® stent. It has been engineered to achieve optimal patient comfort by having an ultra-smooth surface and the ability to soften at body temperature. Add to this an indwelling time of up to 365 days as well as an innovative solution to the problem of urine calcium salt accumulation and you have a product that can continue to live up to the INLAY® stent name.
AccessGUDID Info
- FDA Product Code: FAD
- FDA Product Code Name: STENT, URETERAL
- GMDN Term Code: 58005
- GMDN Term Name: Polymeric ureteral stent
- GMDN Term Description: A sterile non-bioabsorbable tubular device intended to be implanted in an obstructed ureter (e.g., from stone, stricture, compression, fibrosis, trauma) to maintain luminal patency allowing urine to drain from the renal pelvis to the bladder. It is made of a synthetic polymer(s) [e.g., polytetrafluoroethylene (PTFE), polyethylene (PE), silicone], sometimes with a hydrophilic coating (e.g., hydrogel), and may have various designs (e.g., continuous tube with or without drainage side holes, covered or non-covered mesh structure). Disposable devices intended to assist implantation may be included. The device is typically intended for long-term, but not permanent, implantation.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE